Journal of Lipid Research, Vol 33, 209-214, Copyright © 1992 by Lipid Research, Inc.

ARTICLES

Preheparin lipoprotein lipolytic activities: relationship to plasma lipoproteins and postheparin lipolytic activities

DS Glaser, TJ Yost and RH Eckel
Department of Medicine, University of Colorado Health Sciences Center, Denver 80262.

To determine the putative metabolic relevance of preheparin versus postheparin lipoprotein lipases, the relationships of both pre- and postheparin lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) to plasma triglycerides, low density lipoprotein (LDL) cholesterol, and high density lipoprotein (HDL) cholesterol were determined in 93 men. Relationships of preheparin lipases to their respective postheparin lipases were also examined. Although relationships between the preheparin lipases and plasma triglycerides and HDL cholesterol were not apparent, both preheparin LPL (rs = 0.306, P = 0.0036) and HTGL (rs = 0.348, P = 0.0008) correlated with LDL cholesterol, a relationship not seen with either postheparin lipase. Both postheparin LPL (rs = 0.515, P = 0.0001) and postheparin HTGL (rs = -0.228, P = 0.0028), however, correlated with HDL cholesterol. In addition, postheparin LPL was inversely correlated with postheparin HTGL (rs = -0.363, P = 0.0003), whereas the relationship between preheparin LPL and preheparin HTGL was positive (rs = 0.228, P = 0.0009). Overall, these data point to differences between pre- and postheparin lipases in their relationships to lipoproteins, and one to another. The relationships of LDL cholesterol to both preheparin LPL and HTGL suggest that displacement of active forms of both lipases from their endothelial binding sites may mark triglyceride-rich lipoproteins or their remnants for metabolic pathways that lead to LDL.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. K. Pulawa, D. R. Jensen, A. Coates, and R. H. Eckel Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle J. Lipid Res., January 1, 2007; 48(1): 145 - 151. [Abstract] [Full Text] [PDF]

				R. J. Brown, A. Gauthier, R. J. Parks, R. McPherson, D. L. Sparks, J. R. Schultz, and Z. Yao Severe Hypoalphalipoproteinemia in Mice Expressing Human Hepatic Lipase Deficient in Binding to Heparan Sulfate Proteoglycan J. Biol. Chem., October 8, 2004; 279(41): 42403 - 42409. [Abstract] [Full Text] [PDF]

				Y. Park, P. G Jones, and W. S Harris Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids Am. J. Clinical Nutrition, July 1, 2004; 80(1): 45 - 50. [Abstract] [Full Text] [PDF]

				J. Lee, C. S. Tan, K. S. Chia, C. E. Tan, S. K. Chew, J. M. Ordovas, and E. S. Tai The lipoprotein lipase S447X polymorphism and plasma lipids: interactions with APOE polymorphisms, smoking, and alcohol consumption J. Lipid Res., June 1, 2004; 45(6): 1132 - 1139. [Abstract] [Full Text] [PDF]

				X. Galan, J. Peinado-Onsurbe, J. Julve, D. Ricart-Jane, M. Q. Robert, M. Llobera, and I. Ramirez Inactive hepatic lipase in rat plasma J. Lipid Res., December 1, 2003; 44(12): 2250 - 2256. [Abstract] [Full Text] [PDF]

				V. Pruneta, D. Autran, G. Ponsin, C. Marcais, L. Duvillard, B. Verges, F. Berthezene, and P. Moulin Ex Vivo Measurement of Lipoprotein Lipase-Dependent Very Low Density Lipoprotein (VLDL)-Triglyceride Hydrolysis in Human VLDL: An Alternative to the Postheparin Assay of Lipoprotein Lipase Activity? J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 797 - 803. [Abstract] [Full Text]

				T. T. Nguyen, K. E. Kruckeberg, J. F. O’Brien, Z.-S. Ji, P. S. Karnes, T. B. Crotty, I. D. Hay, R. W. Mahley, and T. O’Brien Familial Splenomegaly: Macrophage Hypercatabolism of Lipoproteins Associated with Apolipoprotein E Mutation [Apolipoprotein E ({Delta}149 Leu)] J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4354 - 4358. [Abstract] [Full Text]

				H. E. Henderson, J. J. P. Kastelein, A. H. Zwinderman, E. Gagné, J. W. Jukema, P. W. A. Reymer, B. E. Groenemeyer, K. I. Lie, A. V. G. Bruschke, M. R. Hayden, et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins J. Lipid Res., April 1, 1999; 40(4): 735 - 743. [Abstract] [Full Text]

				E. Zsigmond, Y. Fuke, L. Li, K. Kobayashi, and L. Chan Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro J. Lipid Res., September 1, 1998; 39(9): 1852 - 1861. [Abstract] [Full Text]

				B. Chappey, B. Beyssen, E. Foos, F. Ledru, J. L. Guermonprez, J. C. Gaux, and I. Myara Sialic Acid Content of LDL in Coronary Artery Disease: No Evidence of Desialylation in Subjects With Coronary Stenosis and Increased Levels in Subjects With Extensive Atherosclerosis and Acute Myocardial Infarction : Relation Between Desialylation and In Vitro Peroxidation Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 876 - 883. [Abstract] [Full Text] [PDF]

				P. Tornvall, G. Olivecrona, F. Karpe, A. Hamsten, and T. Olivecrona Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma Lipoproteins Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1086 - 1093. [Abstract] [Full Text]